Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility (Q33904964)

29 July 2017

0 references

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility (English)

1 reference

29 July 2017

1 reference

17

1 reference

29 July 2017

Hanne Meijers-Heijboer

4

Hanne Meijers-Heijboer

0 references

Katherine L Nathanson

Katherine L Nathanson

13

0 references

Gareth Evans

D Gareth Evans

6

0 references

P. Andrew Futreal

12

P Andrew Futreal

1 reference

29 July 2017

7

Diana Eccles

1 reference

29 July 2017

15

Douglas F Easton

1 reference

29 July 2017

16

Michael R Stratton

1 reference

29 July 2017

2

Sheila Seal

1 reference

29 July 2017

10

Jan Klijn

1 reference

29 July 2017

Ans M W van den Ouweland

11

Ans van den Ouweland

1 reference

29 July 2017

5

Marijke Wasielewski

1 reference

29 July 2017

1

Mieke Schutte

1 reference

29 July 2017

3

Rita Barfoot

1 reference

Breast Cancer Linkage Consortium

29 July 2017

18

Breast Cancer Linkage Consortium

1 reference

29 July 2017

Carel Meijers

8

1 reference

29 July 2017

Frans Lohman

9

1 reference

29 July 2017

Barbara L Weber

14

1 reference

29 July 2017

language of work or name

English

0 references

publication date

27 February 2003

1 reference

American Journal of Human Genetics

29 July 2017

1 reference

29 July 2017

72

1 reference

29 July 2017

4

1 reference

29 July 2017

1023-1028

1 reference

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Mutation analysis of the CHK2 gene in breast carcinoma and other cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Chk2 activation and phosphorylation-dependent oligomerization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Analysis of CHK2 in vulval neoplasia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

CHK2 kinase--a busy messenger.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Mutation analysis of the CHK2 gene in families with hereditary breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

The DNA damage response: putting checkpoints in perspective

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Characterization of tumor-associated Chk2 mutations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

The North Cumbria Community Genetics Project

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Concomitant inactivation of p53 and Chk2 in breast cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1180332

Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12610780

12 December 2020

inferred from PubMed ID database lookup

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12610780

12 December 2020

inferred from PubMed ID database lookup

Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12610780

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1086/373965

1 reference

release_rlflbbyzmze33ppnc46ny7choi

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rlflbbyzmze33ppnc46ny7choi

24 November 2022

mapped directly with Wikidata item

PMCID

1180332

1 reference

29 July 2017

1 reference